← All Evotec SE filings

Evotec SE Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
EVO
Evotec SE
SCHEDULE: MAK Capital Secures Board Seat at Evotec SE
MAK Capital Fund LP has entered into a cooperation agreement with Evotec SE, resulting in the nomination of Dr. Wolfgang Hofmann to the company's Supervisory Board.
NASDAQ
EVO
Evotec SE
SCHEDULE: MAK Capital Urges Evotec to Spin Off Just Biologics
Activist investor MAK Capital, holding a 7% stake in Evotec SE, is pushing for a U.S. IPO of Just Biologics and accelerated restructuring to unlock shareholder value.
NASDAQ
EVO
Evotec SE
SCHEDULE: Activist Investor MAK Capital Takes 7% Stake in Evotec SE
MAK Capital has acquired a 7.0% stake in Evotec SE and is pushing for strategic and governance improvements, including a board nomination and a spin-out of Just-Evotec Biologics.
NASDAQ
EVO
Evotec SE
SCHEDULE: Triton Funds Convert Evotec SE Swap to Direct Equity
Triton-affiliated entities, including Excalibur LuxCo SARL, have converted a swap agreement into direct ownership of 3.55 million Evotec SE ordinary shares, maintaining a 9.99% stake.